Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Completion Of Novira Therapeutics, Inc. Acquisition

[PR Newswire] – NEW BRUNSWICK, N.J., Dec. 4, 2015 /PRNewswire/ — Johnson & Johnson (JNJ) today announced the completion of the acquisition of Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing . . . → Read More: Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Completion Of Novira Therapeutics, Inc. Acquisition Similar Articles: Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces $1.75 Million Donation to Save the Children to Support Syrian Humanitarian Refugee Crisis Company Update (NYSE:JNJ): Johnson & Johnson Announces Agreement To Acquire Novira Therapeutics, Inc. Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Consumer Inc. Announces Completion of the Divestiture of SPLENDA® Brand to Heartland Food Products Group